Publications by authors named "Jo Vandervoort"

Claim this Profile
S
Self-expandable metal stents for obstructing colonic and extracolonic cancer: European Society of Gastrointestinal Endoscopy (ESGE) Guideline - Update 2020.
Jeanin E van Hooft, Joyce V Veld, Dirk Arnold, Regina G H Beets-Tan, Simon Everett, Jo Vandervoort

Endoscopy· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An unusual cause of severe, persistent diarrhoea.
Bram Verstockt, Barbara Deleenheer, Filip Sermon, Kris Van Der Steen, Jo Vandervoort

Acta Gastroenterol Belg· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Ten-year survival after endoscopic stent placement as a bridge to surgery in obstructing colon cancer.
Bram Verstockt, Annelien Van Driessche, Marc De Man, Pieter van der Spek, Koen Hendrickx, Jo Vandervoort

Gastrointest Endosc· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Self-expandable metal stents for obstructing colonic and extracolonic cancer: European Society of Gastrointestinal Endoscopy (ESGE) Clinical Guideline.
Jeanin E van Hooft, Emo E van Halsema, Geoffroy Vanbiervliet, Regina G H Beets-Tan, John M DeWitt, Jo Vandervoort

Endoscopy· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Self-expandable metal stents for obstructing colonic and extracolonic cancer: European Society of Gastrointestinal Endoscopy (ESGE) Clinical Guideline.
Jeanin E van Hooft, Emo E van Halsema, Geoffroy Vanbiervliet, Regina G H Beets-Tan, John M DeWitt, Jo Vandervoort

Gastrointest Endosc· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Consecutive fecal calprotectin measurements to predict relapse in patients with ulcerative colitis receiving infliximab maintenance therapy.
Martine De Vos, Edouard J Louis, Jørgen Jahnsen, Jo G P Vandervoort, Maja Noman

Inflamm Bowel Dis· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Self-Expanding Metal Stenting for Palliation of Patients with Malignant Colonic Obstruction: Effectiveness and Efficacy on 255 Patients with 12-Month's Follow-up.
Søren Meisner, Ferran González-Huix, Jo G Vandervoort, Alessandro Repici, Dimitrios Xinopoulos

Gastroenterol Res Pract· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Self-expandable metal stents for relieving malignant colorectal obstruction: short-term safety and efficacy within 30 days of stent procedure in 447 patients.
Søren Meisner, Ferran González-Huix, Jo G Vandervoort, Paul Goldberg, Juan A Casellas

Gastrointest Endosc· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and characterization of Cyclosporine A loaded nanoparticles for ocular drug delivery: Cellular toxicity, uptake, and kinetic studies.
Pelin Aksungur, Murat Demirbilek, Emir B Denkbaş, Jo Vandervoort, Annick Ludwig

J Control Release· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of mucoadhesive poly(lactide-co-glycolide) nanoparticles for ocular application.
Krassimira Yoncheva, Jo Vandervoort, Annick Ludwig

Pharm Dev Technol· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Needle-knife sphincterotomy and post-ERCP pancreatitis: time to lower the threshold for the needle?
Tony C K Tham, Jo Vandervoort

Gastrointest Endosc· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adhesion of PLGA or Eudragit/PLGA nanoparticles to Staphylococcus and Pseudomonas.
Kathleen Dillen, Chris Bridts, Pieter Van der Veken, Paul Cos, Jo Vandervoort

Int J Pharm· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Microneedles for transdermal drug delivery: a minireview.
Jo Vandervoort, Annick Ludwig

Front Biosci· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and validation of an HPLC method for quality control of Pueraria lobata flower.
Lidiya Bebrevska, Luis Bravo, Jo Vandervoort, Luc Pieters, Arnold Vlietinck

Planta Med· December 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cytotoxicity of submicron emulsions and solid lipid nanoparticles for dermal application.
Wim Weyenberg, Plamen Filev, Dave Van den Plas, Jo Vandervoort, Kris De Smet

Int J Pharm· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Ocular drug delivery: nanomedicine applications.
Jo Vandervoort, Annick Ludwig

Nanomedicine (Lond)· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Colonic stents for malignant obstruction--not a bridge too far?
Jo Vandervoort, Tony C K Tham

Gastrointest Endosc· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of ciprofloxacin-loaded Eudragit RS100 or RL100/PLGA nanoparticles.
Kathleen Dillen, Jo Vandervoort, Guy Van den Mooter, Annick Ludwig

Int J Pharm· May 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of roller compaction settings on the preparation of bioadhesive granules and ocular minitablets.
Wim Weyenberg, An Vermeire, Jo Vandervoort, Jean Paul Remon, Annick Ludwig

Eur J Pharm Biopharm· April 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The influence of the use of viscosifying agents as dispersion media on the drug release properties from PLGA nanoparticles.
Kathleen Dillen, Wim Weyenberg, Jo Vandervoort, Annick Ludwig

Eur J Pharm Biopharm· November 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influence of the homogenisation procedure on the physicochemical properties of PLGA nanoparticles.
Jo Vandervoort, Krassimira Yoncheva, Annick Ludwig

Chem Pharm Bull (Tokyo)· November 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Factorial design, physicochemical characterisation and activity of ciprofloxacin-PLGA nanoparticles.
Kathleen Dillen, Jo Vandervoort, Guy Van den Mooter, Loes Verheyden, Annick Ludwig

Int J Pharm· May 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk factors for complications after performance of ERCP.
Jo Vandervoort, Roy M Soetikno, Tony C K Tham, Richard C K Wong, Angelo P Ferrari

Gastrointest Endosc· November 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis